This month, every donation we receive will be matched by a few generous, anonymous donors.
Help the next patient receive the options that they need by joining the Cancer Commons family of donors.
Your philanthropic support allows us to provide treatment options at no charge. It also allows us to develop an online community knowledge base that will transform cancer care. By learning from every patient, we will optimize and expand the use of available treatments far more efficiently than traditional trials and rapidly improve options for all patients with advanced cancer.
In a new interview, oncologist and Cancer Commons Medical Director Dr. Kevin Knopf gives his perspective on the future of cancer research and treatment, including the role of Cancer Commons. He also discusses the potential benefits of value frameworks, which are tools that take a variety of factors into account in order to aid treatment decisions.
Since September 1, 2016, the weekly number of new patients and caregivers seeking help through our ASK Cancer Commons service has increased by about 500%, compared to previous months. This surge occurred organically, with new users finding out about the service solely by word of mouth. Continue reading…
Cancer Commons is featured in a new article about precision medicine published in the scientific journal Nature. Read about our mission and how it fits in with other efforts to empower patients to take a more active role in medical research through data sharing.
Last weekend Cancer Commons representatives attended Tomstock, an annual benefit concert for the H8 Cancer Foundation. In the spirit of Woodstock, Tomstock was a love-in of sorts, especially for cancer patients and survivors. H8 Cancer has provided generous support to Cancer Commons, enabling us to help more people touched by cancer. We are honored and grateful to have been invited to participate at Tomstock 2016.
Above: Host Kiers Rowley (left) and H8Cancer.org founder and CEO Dr. Simeon Jaggernauth at Tomstock 2016. See more photos of the event on our Facebook page.
Cancer Commons founder Marty Tenenbaum’s story of his own battle with melanoma is featured in an article published in The Sydney Morning Herald. The piece outlines how studying “super responders” could help improve cancer treatment for all patients.
Throughout my treatment, peers have helped me learn about my diagnosis, digest information, and move forward. I was lucky to have a team that knew extending the time of my Perjeta injection could have a positive impact on my quality of life. However, I also know that there are other women who are having a similar experience and may not have this specific piece knowledge within their team. I hope this finds you! I want to share the tidbits I gain from my experience so that all patients have access to the same knowledge, regardless of where you are being treated.
—Cat, a metastatic breast cancer patient
The key to defeating cancer is the ability of doctors, researchers, and patients to share knowledge and insights with one another. In the United States, 1.6 million people are diagnosed with cancer each year. An entire population of patients and families is gaining insights into their cancer every day, but these are not being effectively shared. To end cancer, it is imperative that we create a space for patients to be equal partners in the data sharing conversation. Continue reading…
On May 21, HackCancer held its 4th Annual White Party in San Francisco. 100% of the net proceeds go to Cancer Commons and will help us get the right treatments to the right patients at the right time. A huge thank you to the organizers and to all who attended!
Above: Dominique Kim and Toni Alejandria show their support at the HackCancer White Party. See more photos of the event on our Facebook page.